Beth Weinberg

General Counsel bei APNIMED, INC.

Health Technology

Consumer Services

Profil

Beth Weinberg is currently Chief Regulatory & Safety Officer at Apnimed, Inc. Former positions include Vice President & Head-Regulatory at Angion Biomedica Corp., VP, Head-Regulatory Affairs & Quality at Metavant Sciences, Inc., and Senior Vice President-Regulatory Affairs at CARA Therapeutics, Inc. from 2022 to 2024.
Education includes undergraduate studies at Butler University and Bradley University.

Aktive Positionen von Beth Weinberg

Unternehmen	Position	Beginn
APNIMED, INC.	General Counsel	-

Alle aktiven Positionen von Beth Weinberg

Ehemalige bekannte Positionen von Beth Weinberg

Unternehmen	Position	Ende
CARA THERAPEUTICS, INC.	General Counsel	01.07.2024
ANGN BIOM	General Counsel	-
Metavant Sciences, Inc. Metavant Sciences, Inc. Part of Roivant Sciences Ltd., Metavant Sciences, Inc. is a biotechnology company founded in 2014 with the goal of improving the lives of patients by accelerating the development and commercialization of medicines that matter. The company builds nimble subsidiaries called "Vants" to develop and commercialize its medicines and technologies. Metavant Sciences, Inc. has a diverse pipeline of investigational drugs across its family of companies, including Immunovant, Dermavant, and Priovant. Immunovant focuses on developing potentially transformative therapies for autoimmune diseases, while Priovant is developing targeted therapies for severe autoimmune diseases. The company is based in New York.	General Counsel	-

Sehen Sie sich die Erfahrung von Beth Weinberg im Detail an

Ausbildung von Beth Weinberg

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Beth Weinberg im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	6
CARA Therapeutics, Inc. CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed	Health Technology
Butler University Butler University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bradley University Bradley University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Angion Biomedica Corp. Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products	Health Technology
Apnimed, Inc. Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases	Health Technology
Metavant Sciences, Inc. Metavant Sciences, Inc. Part of Roivant Sciences Ltd., Metavant Sciences, Inc. is a biotechnology company founded in 2014 with the goal of improving the lives of patients by accelerating the development and commercialization of medicines that matter. The company builds nimble subsidiaries called "Vants" to develop and commercialize its medicines and technologies. Metavant Sciences, Inc. has a diverse pipeline of investigational drugs across its family of companies, including Immunovant, Dermavant, and Priovant. Immunovant focuses on developing potentially transformative therapies for autoimmune diseases, while Priovant is developing targeted therapies for severe autoimmune diseases. The company is based in New York.